Table 3.
Adolescent Characteristics of Participants as a Function of Group and Medication Treatment Status
ADHD-U (unmedicated) n = 42 | ADHD-M (medicated) n = 48 | Controls n = 80 | F/x2 | p | |
---|---|---|---|---|---|
Gender (M/F) | 36/6 | 43/5 | 71/9 | 0.36 | NSa |
Age: Mean (SD) | 18.24 (1.35) | 18.20 (1.38) | 18.63 (1.64) | 1.61 | NS |
SES: Mean (SD) | 41.6 (17.16) | 45.75 (17.76) | 40.59 (16.56) | 1.42 | NS |
FSIQ: Mean (SD) | 90.02 (11.73) | 95.37 (16.48) | 96.26 (14.91) | 2.57 | NS |
Race | 8.49 | NS | |||
% Caucasian | 19.0 (8/42) | 31.3 (15/48) | 21.3 (17/80) | ||
% African American | 31.0 (13/42) | 16.7 (8/48) | 28.7 (23/80) | ||
% Hispanic or Latino | 26.0 (11/42) | 33.0 (16/48) | 31.0 (25/80) | ||
% Asian | 0.0 (0/42) | 0.0 (0/48) | 2.5 (2/80) | ||
% Mixed/other | 23.8 (10/42) | 18.8 (9/48) | 16.3 (13/80) | ||
ADHD checklist, self-reportb | 14.93 (10.8) | 19.54 (13.5) | 4.66 (5.4) | 38.97 | <.001 |
ADHD checklist, parentb | 21.14 (13.6) | 26.64 (13.7) | 5.74 (7.7) | 57.15 | <.001 |
p > .05.
ADHD-U = ADHD-M > Controls; p < .05.
ADHD-U = attention-deficit/hyperactivity disorder-unmedicated; ADHD-M = attention-deficit/hyperactivity disorder-medicated; Gender M = male; Gender F = female; SES = socioeconomic status; FSIQ = Full Scale IQ; NS = not significant.